Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Practice Point
Nature Reviews Clinical Oncology 1, 68–69 (1 December 2004) | doi:10.1038/ncponc0033
Can weight loss at presentation predict patient outcome in lung cancer?
Abstract
Ross PJ et al. (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?|[nbsp]|Br J Cancer 90: 1905–1911 Synopsis Background Weight loss is a common symptom in patients with lung cancer and mesothelioma. Previous studies have suggested that weight loss at presentation may predict chemotherapy treatment outcome in patients with small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC).
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
